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Abstract. The 30 -ends of the genomes (9538 bp) of two wild-type respiratory bovine coronavirus (RBCV) isolates
LSU and OK were obtained by cDNA sequencing. In addition, the 30 -end of the genome (9545) of the wild-type
enteric bovine coronavirus (EBCV) strain LY-138 was assembled from available sequences and by cDNA
sequencing of unknown genomic regions. Comparative analyses of RBCV and EBCV nucleotide and deduced
amino acid sequences revealed that RBCV-speci®c nucleotide and amino acid differences were disproportionally
concentrated within the S gene and the genomic region between the S and E genes. Comparisons among virulent
and avirulent BCV strains revealed that virulence-speci®c nucleotide and amino acid changes were located within
the S and E genes, and the 32 kDa open reading frame.
Key words: cDNA, S, non-structural, structural, respiratory, coronavirus

Introduction
Coronaviruses are important etiological agents of
human and animal diseases including respiratory
infection, gastroenteritis, hepatic and neurological
disorders as well as immune-mediated disease such
as feline infectious peritonitis, and other persistent
infections (1,2). Enteric bovine coronaviruses
(EBCV) are generally associated with enteric disease
of newborn calves and winter dysentery of adult cattle
(2). Recently, numerous respiratory bovine coronaviruses (RBCV) were isolated in our laboratory from
cattle arriving with fever and respiratory disease in
feedlots or livestock shows of 8 different states in the
USA. The cytopathogenic, cell fusion, and other
phenotypic properties of these viruses were different
from the known EBCV (3).
*Corresponding Author.
The nucleotide sequence data reported in this paper have been
submitted to the GenBank nucleotide sequence database and have
been assigned the accession number AF058942, AF058943,
AF058944.

Coronaviruses contain a single stranded, capped,
and polyadenylated positive-sense (infectious) RNA
molecule of approximately 30 kb length, which directs
the synthesis of a nested set of subgenomic mRNAs
(4,5). The 30 -end of the genomic RNA consists of
approximately 9.5 kb and contains the spike (S)
glycoprotein, the hemagglutinin-esterase (HE) glycoprotein, the integral membrane (M) protein, the small
membrane protein (E) and the phosphorylated nucleocapsid (N) protein and a number of ORFs potentially
encoding non-structural proteins (Ns) (5). The 32 kDa
non-structural protein is a phosphoprotein that
accumulates in the cytoplasm of infected cells (6,7).
It is not known whether the 12.7 and 4.8 kDa ORFs are
expressed in infected cells, while the 4.9 kDa putative
protein, most likely, is not translated (8).
BCV uses N-acetyl-9-O acetyl neuraminic acid
as receptor determinant to initiate infection (9).
Although the HE glycoprotein also has an af®nity
for 9-O-acetylated sialic acid, the S glycoprotein was
identi®ed as the major sialic acid binding protein
of BCV (10). The S glycoprotein facilitates viral
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attachment to susceptible cells, causes cell fusion
after cell-surface expression (fusion from within), and
induces viral infectivity neutralizing antibodies (1).
Porcine transmissible gastroenteritis virus (TGEV)
strains were isolated which exhibited respiratory
tissue tropism. These viruses contained point mutations or deletions within the ®rst 250 aa of TGEV S1
which were associated with reduced enteropathogenicity and loss of hemagglutinating activity (11±13).
To examine the genetic basis for the phenotypic
differences between RBCV and EBCV, we cloned and
sequenced the 30 -end of the viral genomes of two virus
strains RBCV-LSU-94LSS-051-2(LSU) and RBCVOK-0514-3(OK) that originated from Louisiana and
Oklahoma cattle, respectively. We report here, the
nucleotide and predicted amino acid sequences of all
genes encoded by the 30 genomic portion (9.5 kb) of
two wild-type RBCV strains and comparisons among
respiratory and enteric coronaviruses.

Materials and Methods
Viruses and cell line. All RBCV and EBCV strains
were propagated in the G clone of human rectal tumor
cells (HRT-18G) developed recently through selection and medium modulation (3). Supernatant ¯uids
from infected HRT-18G cells were collected and
viruses were puri®ed as described (14). RBCV OK
and LSU virus stocks were tested at the third and
fourth passages, respectively. EBCV LY-138(LY)
virus stocks were prepared at the second passage,
while the EBCV-L9 virus strain, derived from the
EBCV-Mebus strain, had been propagated 80 times in
cell cultures.
Strategy for cDNA construction and assembly of the
9.5 Kb cDNA sequence representing the 30 -end of
different BCV strains. TRI Reagent from the
Molecular Research Center, Inc. (Cincinnati, OH,
USA), was used for total RNA extraction. Ready-ToGo You-Prime First-Strand Beads from Pharmacia
Biotech Inc. (Uppsala, Sweden) were used for cDNA
library construction. All ampli®cations were performed using the Gene-Amp PCR system 9600
(Perkin-Elmer, Norwalk, CT, USA) with PCR
reagents and AmpliTaq from Perkin-Elmer. The TAcloning kit from Invitrogen Inc. (San Diego, CA) was
used for cloning of RT-PCR products. Restriction

enzymes were obtained from New England Biolabs
(Beverly, MA, USA).
The 30 genomic end of BCV Mebus strain
consisting of 8695 nucleotides was assembled from
available sequences deposited in Genbank. The
accession numbers of the cDNA sequences used to
assemble the EBCV Mebus genome were M31053 for
S and HE genes, M31054 for the 4.9, 4.8, 12.7 and
9.5 kDa (E) ORFs, and M16620 for the M, N genes
and I ORF. The assembled Mebus genomic sequence
did not contain the 32 kDa ORF. An 850 nt sequence
containing the 32 kDa ORF of BCV-Quebec (accession number X15445) was used for comparisons with
other BCV. The S and HE cDNA sequences speci®ed
by LY-138 were previously reported (15,16).
A series of overlapping cDNA clones representing
the entire 30 -end of two RBCV isolates and
unpublished sequences of LY-138 were constructed.
Two cDNA libraries were produced, a library was
made using the BCV30 primer representing the 30
terminus of the genomic RNA, and a second cDNA
library was produced using an oligonucleotide (3B11)
to prime cDNAs starting at nucleotide 6345 (counting
from the 30 -end of the viral genome) (Fig. 1). The
entire 9545 nt sequence representing the 30 -end of the
BCV genome was divided into six overlapping cDNA
regions. Each cDNA was ampli®ed by PCR using
speci®c primer pairs. Primer pair 5F6/BCV 30
ampli®ed a cDNA fragment containing the M and N
genes. Primer pair 5F5/3B3 ampli®ed a cDNA
fragment containing the 30 -end of S, 4.9 kDa,
4.8 kDa, 12.7 kDa, E, M and the 50 -end of N genes.
Primer pair B50 /B30 ampli®ed the 30 -end of the spike
gene, primer pair 5F24/A30 ampli®ed a cDNA that
coded for the carboxy-terminal portion of the S1
subunit, primer pair A50 /3B11 ampli®ed a cDNA
fragment that coded for the amino-terminus of S, and
primer pair 5F16/3B10 ampli®ed the 32 kDa and HE
genes. B30 and A50 primers were designed to contain
an extra BamHI and EcoRI sites for cloning purposes,
while a BstXI site was naturally present in the 5F24
primer. The actual primer sequences are:
BCV30 :50 GTGATTCTTCCAATTGGCC;
B50 :50 TCTTCGACAGCTGCAACC;
A30 :50 GGTTGCAGCTGTCGTGAAAGA;
B30 :50 AACGGATCCAATATATCGTCAGGAGCC;
A50 -50 :GCTGAATTCGATAATGGTACTAGGCTG;
5F16-50 :AGAATGGCAGTTGCTTATG;
5F24-50 :TCT-CCATTAAATTGGGAACGTAAG;
3B10-50 :GATTATGGTCTAAGCATCATG;

Fig. 1. BCV genome arrangement and cDNA cloning and sequencing strategy. Top line depicts the  stranded RNA genome of BCV with a truncation marking (//) separating
the 50 portion of the genome coding for the RNA-dependent RNA polymerase (Pol) from the remaining BCV genes. The second line diagrams two cDNA libraries produced by reverse
transcription of the BCV genome using oligonucleotide primers BCV30 and 3B11. Coding sequences for each gene are indicated as ®lled rectangular boxes. The approximate location
of oligonucleotide primers used for RT-PCR and cloning of individual cDNAs are shown as arrows pointing towards the direction of cDNA synthesis.
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3B11-50 :GGTCTTACGTTCCCAATTTAATGG;
5F5-50 :GGTATAGCCCCTAAGAGTG;
5F6-50 :GTTTAATAGAGGTAGGCAG;
3B3-50 :GGTAGCTGAGAAGTAGCAG.

12.7 kDa ORFs of RBCV. The locations for these
ORFs were: ORF4 (4.9 kDa, 6233±6367), ORF5
(4.8 kDa, 6403±6540), ORF6 (12.7 kDa, 6624±
6953), ORF7 (E, 6940±7194), ORF8 (M, 7209±
7901), ORF9 (N, 7911±9257), and ORF10 (I, 7972±
8595).

DNA sequencing and analyses. DNA sequencing
was carried out with the modi®ed dideoxynucleotide
chain termination procedure (17) using SequenaseTM
from Amersham Life Science (Arlington Heights, IL).
All sequencing data were based on sequences
obtained from at least two independently cloned
cDNA fragments. DNA sequences were analyzed
with the aid of the Sequence Analysis Software
Package of the Genetics Computer Group of the
University of Wisconsin and the MacVector Software
(IBI, New Haven, CT). Sequence data obtained from
all overlapping cDNA clones were compiled using the
program AssemblLine of the MacVectorTM software
package running on a Power Macintosh Computer.
Consensus sequences of 9538 bp were produced for
LSU and OK strains, and 9545 bp for the LY-138
strain (Genbank accession numbers AF058942,
AF058943, AF058944 respectively). Analysis of
the cDNA sequence data using the MacVector
software package revealed 10 major ORFs: ORF1
(32 kDa, 15±851), ORF2 (HE, 863±2137), ORF3 (S,
2152±6243), ORF4 (4.9 kDa, 6233±6364), ORF5
(4.8 kDa, 6400±6537), ORF6 (12.7 kDa, 6617±
6946), ORF7 (E, 6933±7187), ORF8 (M, 7202±
7894), ORF9 (N, 7904±9250), and ORF10 (I, 7965±
8588) for LSU and OK strains. The corresponding
locations of ORFs starting from 4.9 kDa ORF were
different for LY-138, because of a codon insertion in
the 4.9 kDa ORF of LY-138 and the four nucleotide
deletion in the intergenic region between 4.8 and

Results
Overall comparisons of genes and predicted proteins
speci®ed by RBCV (LSU, OK) and EBCV (LY, Mebus)
strains. To establish the close evolutionary relationship between LSU and OK strains and to ascertain
RBCV-speci®c amino acid changes (conserved in
LSU and OK but different in other strains), a pairwise
comparison of nucleotide and amino acid differences
among BCV strains for all ORFs, except for the ORF
coding for the RNA-dependent-RNA-polymerase and
the 32 kDa protein was performed (Table 1). In
general, the nucleotide and amino acid sequences of
RBCV strains LSU and OK were more conserved to
each other than to EBCV strains LY-138 and Mebus,
and they were more divergent to the Mebus strain than
to the LY-138. Speci®cally, the amino acid sequence
of M speci®ed by LSU and OK were identical, while
they were different by one, and two aa from that of
Mebus and LY-138, respectively. The S glycoprotein
speci®ed by LSU differed by only 4 amino acids from
that of OK, while S glycoproteins of LSU and OK
differed by 22 and 33 amino acids in comparison with
the LY and Mebus S sequences, respectively.
Furthermore, LSU and OK sequences of the N and I
ORF (located within N) were more conserved to each
other than to any other strain compared. Most amino

Table 1. The nucleotide and amino acid changes for each ORF of different BCV strains
Strain

Compared
to Strain

HE
1272 (424)*

S
4089 (1363)

4.9 kDA
129 (43)

4.8 kDa
135 (45)

12.7 kDa
327 (45)

E
252 (84)

M
690 (230)

N
1344 (448)

I-ORF
621 (207)

OK
LY

LSU
LSU
OK
LSU
OK
LY

11 (4)#
23 (5)
20 (5)
24 (6)
23 (6)
13 (3)

29
68
64
70
66
57

2 (2)
7 (4)
7 (4)
3 (3)
3 (3)
4 (1)

5
8
8
8
7
5

3 (2)
4 (1)
5 (3)
5 (1)
6 (3)
1 (0)

0
1 (0)
1 (0)
2 (1)
2 (1)
1 (1)

1
6
7
4
5
2

4 (2)
16 (4)
12 (4)
17 (5)
13 (3)
9 (3)

3 (2)
9 (6)
6 (4)
10 (8)
7 (6)
5 (4)

Mebus

(4)
(22)
(22)
(33)
(33)
(26)

(4)
(6)
(5)
(5)
(4)
(2)

(0)
(2)
(2)
(1)
(1)
(1)

* indicate the total number of nucleotides and amino acids for each gene.
# comparisons show the total number of nucleotide and amino acid substitutions (in parenthesis) for each ORF.
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acid changes within HE, 4.9, 4.8, 12.7 kDa ORFs, E,
N and the I ORF were strain-speci®c. HE and M
contained one RBCV-speci®c aa change, and N and
I ORF contained two RBCV-speci®c aa changes
each.
RBCV-speci®c amino acid substitutions within S.
The S1 subunit contained most of the RBCV-speci®c
aa substitutions and included an amino acid change
within the signal sequence as well as two clusters of
amino acid substitutions within the amino-terminus
and the hypervariable region (Fig. 2). The proteolytic
cleavage site that separates S1 and S2 subunits was
conserved among RBCV, LY-138 and Mebus strains.
In contrast to the high number of RBCV-speci®c
substitutions within S1, S2 contained only two
RBCV-speci®c amino acid changes, an Ala 769 to
Ser change immediately adjacent to the proteolytic
cleavage site and an Asp 1026 to Gly located within
the heptad repeat sequence. The RBCV-G95 strain
was isolated from a nasal sample of a calf that had
diarrhea and signs of respiratory distress (18). The
nucleotide and predicted primary structures of S and
HE glycoproteins speci®ed by RBCV-G95 were
reported previously (19,20). LSU and OK had ten
unique aa substitutions within S in comparison to all
other BCV strains, while G95, LSU, and OK shared
only three aa substitutions at aa 100, aa 465, and
aa 1026 (Fig. 2).
RBCV-speci®c nucleotide and amino acid substitutions within the 4.9, 4.8, and 12.7 kDa ORFs. The
human coronavirus strain OC43 (HCV-OC43) lacks
two ORFs which potentially encode two nonstructural proteins of 4.9 and 4.8 kDa (21).
Furthermore, the same genomic areas are deleted in
three Hemagglutinating Encephalomyelitis Virus
(HEV) strains of swine (22). The fact that respiratory
HCV-OC43 and EBCV strains show remarkable
genomic and protein similarities as well as immunological cross-reactivities, prompted us to compare the
nucleotide sequences speci®ed by the genomic region
between the S and the 12.7 kDa ORF of EBCV,
RBCV, HCV-OC43, and three porcine HEV strains
(Fig. 3). LSU and OK contained a deletion (TAAT) in
comparison with Mebus as well as LY-138. This
deletion was located 31±34 bp upstream from the
AUG of the 12.7 kDa ORF in the genomic region
between the 4.8 kDa and 12.7 kDa ORFs. The
nucleotide sequences downstream (30 ) to this deletion
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were highly conserved among all strains. The
12.7 kDa ORF of LSU and OK contained the aa
substitution of Lys 5 to Arg, while the aa substitutions
of Ile 8 to Thr, and Glu 21 to Asp were unique for
OK.
Comparison of the Mebus and L9 strains against
virulent (LSU, OK, LY, F15) strains. To examine the
evolutionary relationship of virulent strains to the
avirulent, cell adapted strains, and to delineate
speci®c amino acids which may cause loss of
virulence, a comparison was performed between L9,
Mebus and all other strains. The E protein which is
encoded by the 9.5 kDa ORF contained one aa
substitution (Gly 53 to Val) which was conserved
for all virulent strains (F15, LY-138, OK, LSU) in
comparison to the avirulent Mebus and L9 strains.
Two other RBCV strains from Texas and Arizona
cattle also contained the same aa substitution (data not
shown). Four aa changes in S1 at aa 33, aa 40, aa 278
and aa 470 and three aa substitutions in S2 at aa 965,
aa 1241 and aa 1341 were conserved in all virulent
strains in comparison to Mebus and L9 (Fig. 2) as well
as Norden Vaccine, and EBCV-Quebec strains (data
not shown). The 32 kDa ORF codes for a nonstructural phosphoprotein that accumulates in the
cytoplasm of infected cells (6,7). The EBCV-Quebec
sequence of the 32 kDa ORF was used for comparison, because the 32 kDa nucleotide sequence of the
Mebus strain was not available. DNA sequencing of
three independently derived cDNA clones for each
strain revealed the presence of a single nucleotide (A)
insertion at position 757 (aa 253) speci®ed by both
LSU and OK altering the translational reading frame
for the next 9 aa until a double nucleotide insertion
(AA) at nucleotides 784 and 785 restored the original
frame. LY-138 speci®ed a similar 9 aa peptide which
contained one aa change, Ser to Phe at aa 254 in
comparison to RBCV. In contrast, the corresponding
genomic region of the avirulent EBCV-Quebec strain
speci®ed an 8 aa sequence which was different than
the 9 aa sequence speci®ed by virulent EBCV and
RBCV strains. Two additional amino acid changes,
Ser (192) to Ile and Pro (aa 273) to Ser (274), located
at the carboxy terminal portion of the 32 kDa ORF,
were speci®c for all virulent strains (Fig. 4). Identical
aa changes were also found in the 32 kDa protein of
two more RBCV strains isolated from Texas and
Arizona cattle (data not shown).
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Discussion
Genetic comparisons among different BCVs revealed
substantial differences between RBCV and EBCV
strains principally within the S gene and within ORFs
located between the S and E genes. Furthermore,
genetic differences between virulent and avirulent
strains were identi®ed within the S gene, the E gene
and the 32 kDa ORF. The salient features of genetic
differences between RBCV and EBCV strains are
discussed below:
RBCV-speci®c genetic alterations in the S gene. A
pairwise alignment of TGEV and MHV S aa
sequences revealed that the N-terminal portion of S1
which is deleted in the porcine respiratory coronaviruses (PRCV) and HCV-229E, in comparison with
TGEV, is the region corresponding to the MHV
receptor binding-site (aa 1±330) (23). The TGEV
receptor-binding site is in a different location (aa 500±
700) and aligns with the S polymorphic region of the
MHV strain. Recently, it was shown that only two aa
changes at the N-terminus of TGEV S resulted in the
loss of enteric tropism (13). The S1 amino terminus
speci®ed by RBCV strains LSU and OK contained aa
changes at aa11, aa115, aa118, aa173 and aa179
which may affect S1-mediated receptor binding.
Hemagglutination of chicken red blood cells (RBC)
was shown to be mediated by the S glycoprotein,
because puri®ed S of the EBCV Mebus strain
agglutinated chicken RBC, while puri®ed HE did
not (10,24). RBCV strains LSU and OK agglutinated
mouse and rat, but not adult chicken RBC (3).
Therefore, aa changes within S speci®ed by RBCV
may be responsible for the inability to hemagglutinate
chicken RBC.
The S1A virus neutralizing (VN) immunoreactive
epitope (aa 351±403) (25) was identical for all viral
strains, except for a single aa change at aa 362
speci®ed by the avirulent, cell culture-adapted strain
EBCV-L9 (Fig. 2). Furthermore, the S1A epitopes of
HCV-OC43 and the BCV Mebus strain were identical
(21). Monoclonal antibodies (MABS) against the
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EBCV Mebus cross-reacted with different animal and
human coronaviruses (25). Therefore, it is likely that
these antibodies react with the S1A epitope. The
hypervariable region of the S glycoprotein contains
the S1B immunoreactive epitope which is the target
for virus neutralizing Mabs (25). Four RBCV-speci®c
aa substitutions at aa 510, aa 531, aa 543 and aa 578
were located within or proximal to this epitope. Based
on the observed aa changes, it can be predicted that
Mabs speci®c for this region may be able to
distinguish between respiratory, enteric and vaccine
BCV strains.
The BCV S2 subunit of S induced cell fusion when
it was expressed in insect cells, indicating that S2
contained membrane fusion domains (26). The
hydrophobic and heptad repeat regions of S2 are
believed to form the coiled-coil structure of the
oligomeric S protein that have been associated with
fusion activity. Speci®cally, three aa changes within a
predicted heptad region of the MHV S2 subunit were
shown to be responsible for pH-dependent cell fusion
(27). RBCV strains LSU and OK are highly fusogenic
in cell culture (data not shown). Additional experimentation is required to assess whether the aa change
of Ala 769 to Ser immediately after the proteolytic
cleavage site and the aa change of Asp 1026 to Gly
within the heptad repeat are responsible for the
extensive cell fusion induced by RBCV.
RBCV-speci®c genetic alterations between the S and
E genes. The RBCV genomic regions between the S
and E genes contained many nucleotide substitutions,
deletions and insertions. HCV-OC43 and three
porcine HEV strains speci®ed deletions within the
4.9 and 4.8 kDa ORFs, indicating that they are not
essential for virus replication. Similarly, the high
number of mutations within the RBCV 4.8 and
4.9 kDa ORFs suggests that these ORFs are not
essential for virus replication in cell culture (Table 1).
The 65 nt leader of a cloned BCV defective interfering
(DI) RNA when mapped by mutations, could be
converted rapidly to the wild-type leader of a helper
virus following DI RNA transfection into helper

Fig. 2. Comparison of the predicted amino acid sequences of the BCV S glycoprotein speci®ed by different strains. Amino acids
that are different in at least one strain are shown, except aa 1, aa 768 and aa 1363 which are included as reference points. * indicates
unique amino acid changes for each strain. Boxed amino acids are common among different strains. Light-gray boxes contain RBCVspeci®c, dark boxes contain virulent-speci®c, and clear boxes contain EBCV-speci®c aa changes. aa 1±17 is the putative signal peptide; aa
351±403 is the S1A immunoreactive domain; aa 517±621 is the S1B immunoreactive domain; aa 452±593 is the hypervariable region; aa
955±992 is the hydrophobic region; aa 993±1032 is the heptad repeat sequence; aa 1312±1325 is the carboxy-terminal anchor sequence.
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Fig. 3. Alignment of BCV nucleotide sequences spanning the region demarkated by the 30 end of the S gene and the 50 end of the
12.7 kDa ORF. Alignment was performed using the multiple sequence alignment with the hierarchical clustering software MultAlin (33).
The leader-mRNA junction sequences are underlined. Start and stop codons for each ORF are represented by bolded letters. Nucleotide
deletions are noted as dotted lines. Nucleotide differences among strains are noted as small letters, while conserved nucleotides are capital
letters.

Fig. 4. Comparison of the predicted amino acid sequences of the 32 kDa ORF speci®ed by different BCVs. Amino acids which are different in each BCV strain in comparison
to BCV-Quebec are shown. * represent amino acid differences from BCV-Quebec. Amino acids in each BCV strain which are different from the BCV-Quebec as the result of the
double-frame shift mutations are represented by bolded letters.

G

G

G

G
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virus-infected cells (28). Nucleotide substitutions
mapped the crossover region to a 24-nucleotide
segment that starts from the last nt of the leadermRNA junction sequence and extends further downstream. The RBCV isolates LSU, OK, as well as
RBCV AZ-26649-2 (AZ) and TX-671-2 (TX) isolated
from California and Texas cattle, respectively (data
not shown), contained a four nucleotide deletion
located within this 24 nucleotide segment (Fig. 3).
This deletion may alter the recombination frequency
between the leader and the leader-mRNA junction
sequence immediately upstream of the 12.7 kDa
subgenomic mRNA, and cause either inhibition or
enhancement of the putative 12.7 kDa transcription
and subsequent protein expression.
Genetic differences between virulent and avirulent
BCV strains. The S glycoprotein contained 7 aa
substitutions which were common for all virulent
strains (aa 33, 40, 248, 470, 965, 1241 and 1341).
Three mutations within the SI portion of S caused
conservative aa changes, while one non-conservative
aa change of His 470 to Asp was located within the S1
hypervariable region. All three mutations within S2
caused non-conservative amino acid changes. Amino
changes within S1 and S2 may affect the structure and
function of the S glycoprotein and alter the
pathogenetic potential of these viruses. The 32 kDa
ORF speci®ed by RBCV virulent strains LSU and OK
as well as EBCV LY-138 contained two frame-shift
mutations which resulted in a 9 aa segment near the
carboxy-terminus which was different from the
corresponding amino acid sequence speci®ed by the
avirulent EBCV-Quebec strain (Fig. 4). A similar
double frame shift mutation was found in the 32 kDa
ORF speci®ed by HCV-OC43 (29). These frame shift
mutations increased substantially the hydrophilicity
of the carboxy terminal portion of the 32 kDa protein
in virulent versus avirulent strains (data not shown).
Sequencing of the corresponding region of the 32 kDa
protein of the avirulent EBCV L9 and Mebus strains
as well as the 32 kDa of other virulent strains will
substantiate these differences between virulent and
avirulent strains. The aa substitution of Gly 53 to Val
in the E protein was conserved for all BCV virulent
strains (F15, LY-138, OK, LSU), HCV-OC43 (30),
and three different porcine HEV strains (22). This
mutation may affect the ability of these viruses to
invade different tissues, because E is part of the virion
and is expressed at infected cell-surfaces (31,32).

42

Chouljenko et al.

Acknowledgments
We acknowledge the technical assistance of Mamie
Burrell with cell culture and virus propagation, and
Galina Rybachuck with sequence analysis and design
of ®gures. This work was supported in part by USDA
Grant 94-3704-0926 of the National Research
Initiative Program to J.S. and K.G.K., Louisiana
Educational Support Fund (LEQSF) Grant XRF/19951998-RD-B-18 to J.S. and K.G.K., LEQSF grant RD1993-1998-RD-B-04 to K.G.K., and a grant from
Immtech Biologics, Inc., Bucyrus, KS. We are
indebted for support by the LSU School of
Veterinary Medicine. This publication is identi®ed
as GeneLab publication #GL1201.
References
1. Spaan W., Cavanagh D., and Horzinek M.C., J Gen Virol 69,
2939±2952, 1988.
2. Wege H., Siddell S., and ter Meulen V., Curr Top Microb &
Immunol 99, 165±200, 1982.
3. Storz J., Stine L., Liem A., and Anderson G.A., J Am Vet Med
Assoc 208, 1452±1455, 1996.
4. Lai M.M.C., Annu Rev Microbiol 44, 303±333, 1990.
5. Lai M.M. and Cavanagh D., Adv Virus Res 48, 1±100,
1997.
6. Cox G.J., Parker M.D., and Babiuk L.A., Nuc Acids Res 17,
5847, 1989.
7. Cox G.J., Parker M.D., and Babiuk L.A., Virology 185, 509±
512, 1991.
8. Hofmann M.A., Chang R.Y., Ku S., and Brian D.A., Virology
196, 163±171, 1993.
9. Schultze B. and Herrler G., J Gen Virol 73, 901±906,
1992.
10. Schultze B., Gross H.J., Brossmer R., and Herrler G., J Virol 65,
6232±6237, 1991.
11. Rasschaert D., Duarte M., and Laude H., J Gen Virol 71, 2599±
2607, 1990.
12. Krempl C., Schultze B., Laude H., and Herrler G., J Virol 71,
3285±3287, 1997.

13. Ballesteros M.L., Sanchez C.M., and Enjuanes L., Virology
227, 378±388, 1997.
14. Storz J., Zhang X.M., and Rott R., Arch Virol 125, 193±204,
1992.
15. Zhang X.M., Kousoulas K.G., and Storz J., Virology 185, 847±
852, 1991.
16. Zhang X.M., Kousoulas K.G., and Storz J., Virology 183, 397±
404, 1991.
17. Sanger F., Nicklen S., and Coulson A.R., Proc Nattl Acad Sci
USA 74, 5463±5467, 1977.
18. Jimenez C., Herbst W., Biermann U., Muller J.M., and
Schliesser T., Zentralblatt Fur Veterinarmedizin. Reihe B 36,
635±638, 1989.
19. Zhang X.M., Kousoulas K.G., and Storz J., Virology 186, 318±
323, 1992.
20. Zhang X., Herbst W., Kousoulas K.G., and Storz J., Arch Virol
134, 421±426, 1994.
21. Mounir S. and Talbot P.J., J Gen Virol 74, 1981±1987, 1993.
22. Vieler E., Schlapp T., and Herbst W., J Gen Virol 77, 1443±
1447, 1996.
23. Laude H., et al. in Talbot P.J. and Levy G.A. (eds). Corona and
related viruses: Functional domains in the spike protein of
transmissible gastroenteritis virus. Plenum Press, New York,
pp. 299±394, 1995.
24. Schultze B., Wahn K., Klenk H.D., and Herrler G., Virology
180, 221±228, 1991.
25. Cavanagh D. in Siddell S.G. (ed.). The Coronaviridae: The
coronavirus surface glycoprotein. Plenum Press, New York and
London, pp. 73±113, 1995.
26. Yoo D.W., Parker M.D., and Babiuk L.A., Virology 180, 395±
399, 1991.
27. Gallagher T.M., Escarmis C., and Buchmeier M.J., J Virol 65,
1916±1928, 1991.
28. Chang R.Y., Krishnan R., and Brian D.A., J Virol 70, 2720±
2729, 1996.
29. Labonte P., Mounir S., and Talbot P.J., J Gen Virol 76, 431±435,
1995.
30. Mounir S., Labonte P., and Talbot P.J., Adv Exp Med & Biol
342, 61±67, 1993.
31. Brown T.D.K. and Brierly I., in Siddell S. (ed.) The
Coronaviridae: The Coronavirus Non-Structural Proteins.
Plenum Press, New York and London, pp. 191±217, 1995.
32. Godet M., L'Haridon R., Vautherot J.F., and Laude H.,
Virology 188, 666±675, 1992.
33. Corpet F., Nucl Acids Res 16, 10881±10890, 1988.

